ImmunityBio, Inc. (NASDAQ: IBRX) faces a securities class action lawsuit which seeks to represent investors who purchased or otherwise acquired ImmunityBio securities ...
Enduring a tough stretch better than most. Our research team assigns Silver ratings to strategies that they have a high conviction will outperform the relevant index, or most peers, over a market ...
A topnotch large-growth offering. Our research team assigns Gold ratings to strategies that they have the most conviction will outperform a relevant index, or most peers, over a market cycle on a risk ...
The Renault 5 isn’t the first car from a bygone era to make a comeback, but it's proving just as successful as other efforts, including the reimagined Fiat 500 and Mini. Indeed, the hatchback that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results